Related Experiment Video

Updated: Jun 24, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Implementation of specialty centers for patients with ST-segment elevation myocardial infarction

Marc Eckstein1, William Koenig, Amy Kaji

  • 1Keck School of Medicine of the University of Southern California, Los Angeles, California 90033, USA. eckstein@usc.edu

Prehospital Emergency Care
|March 18, 2009
PubMed

Insights

A regional system effectively identifies ST-segment elevation myocardial infarction (STEMI) patients using prehospital ECGs. This approach achieved door-to-balloon times under 90 minutes for nearly 90% of STEMI patients receiving primary PCI.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Public Health Systems

Background:

  • Percutaneous coronary intervention (PCI) is superior to fibrinolytic therapy for ST-segment elevation myocardial infarction (STEMI).
  • Early intervention reduces morbidity and mortality in STEMI patients.

Purpose of the Study:

  • Evaluate a regional system for prehospital identification and direct transport of STEMI patients.
  • Assess the performance of STEMI receiving centers (SRCs) in providing primary PCI.

Main Methods:

  • Prospective study of a regional SRC network's first year.
  • Analysis of prehospital 12-lead ECG identification of STEMI.
  • Tracking key time intervals from patient contact to PCI.

Main Results:

  • 1,220 suspected STEMI patients identified via prehospital ECG.
  • 734 patients (60%) underwent emergency PCI.
  • Door-to-balloon times <90 minutes achieved for 89% of patients.

Conclusions:

  • Regionalized STEMI care with prehospital ECGs significantly improves PCI timeliness.
  • Nearly 90% of STEMI patients met the 90-minute door-to-balloon benchmark.
  • The system demonstrates effective STEMI patient management and outcomes.
Abstract

More Related Videos

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...